Profilo
Tanya Fischer, formerly Head of Translational Medicine at Alnylam Pharmaceuticals, Inc., and Associate Professor at Yale University, also served as the Chief Development Officer at Biohaven Ltd.
from 2022 to 2023.
Precedenti posizioni note di Tanya Fischer
| Società | Posizione | Fine |
|---|---|---|
| BIOHAVEN LTD. | Corporate Officer/Principal | 01/10/2023 |
| Yale University | Corporate Officer/Principal | - |
| ALNYLAM PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
3
Relazioni di 1° grado
3
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
| BIOHAVEN LTD. | Health Technology |
- Borsa valori
- Insiders
- Tanya Fischer
